Abstract
The Potential Survival Advantages of Rivaroxaban in Patients with COVID-19 and its Relationship with D-Dimer Levels at the Time of Early Onset of Anticoagulation
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Science and Research (IJSR)
Paper Title
Journal
Date
